Affimed NV logo

AFMD - Affimed NV News Story

$3.85 0.0  1.0%

Last Trade - 10/08/20

Sector
Healthcare
Size
Small Cap
Market Cap £244.8m
Enterprise Value £167.2m
Revenue £13.7m
Position in Universe 3363rd / 6393

BRIEF-Affimed NV Says Announced Completion Of First Dose Cohort In Phase 1/2A Clinical Trial Of AFM24

Wed 17th June, 2020 12:11pm
June 17 (Reuters) - Affimed NV  A28.F :
    * AFFIMED NV - ANNOUNCED SUCCESSFUL COMPLETION OF FIRST DOSE
COHORT IN PHASE 1/2A CLINICAL TRIAL OF AFM24

Source text for Eikon:  ID:nGNX3ZTCCj 
Further company coverage:  A28.F 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.